AIM movers: GENinCode FDA filing and Tern profit-taking

GENinCode (LON: GENI) has filed its premarket notification (510k) with the US FDA for the CARDIO inCode-Score polygenic test for the risk assessment and prevention of heart disease. The test uses data collated over 15 years. The company’s US laboratory has gained accreditation from the College of American Pathologists. The share price steadily improved during the morning and is up 17.4% to 13.5p.

Belluscura (LON: BELL) has orders for 6,500 DISCOV-R portable oxygen concentrators and received 1,500 X-PLOR units to sell. The DISCOV-R order is worth $15m – 2022 revenues were $1.5m – with production beginning in the third quarter. The share price increased 16.2% to 43p, which is the highest since March.

- Advertisement -

Chaarat Gold (LON: CGH) has agreed a bonding conditional sale of its subsidiary that owns the Kapan mine in Armeina to Gold Mining Company, which owns the nearby Lichkvaz mine. The deal is worth $55.4m. Kapan needs significant investment and exchange rates had hit profitability. Chaarat will focus on the Xiwang project. The share price rose 8.52% to 7.325p.

Staffing firm Gattaca (LON: GATC) expects net fee income to be below forecasts, but the pre-tax profit is likely to be higher than expected because of cost control. Liberum has upped its estimate from £1.8m to £2.5m. However, it has cut its 2023-24 estimate by one-quarter to £3m. The share price is 9.84% ahead at 106p.

Eden Research (LON: EDEN) has received its first commercial order for seed treatment Ecovelex from partner Corteva Agriscience. This treatment replaces chemicals that may be banned. Full authorisations have yet to be received, but it can be sold under emergency use authorisations.  The share price is 6.52% ahead at 6.125p.

Technology investment company Tern (LON:TERN) reported a decline in NAV from 6.4p/share to 5.7p/share over the six months to June 2023. The 12.5% decline in the share price to 5.25p probably has more to do with continued profit-taking following the rise after investee company Wyld Networks said it was exploring potential areas of collaboration with SpaceX. Tern owns 27% of Wyld Networks.

- Advertisement -

Serinus Energy (LON: SENX) shares continue to decline following its announcement on Monday that lower oil and gas prices mean that interim revenues slumped from $29.3m to $8.9m. Net cash was $2.5m at the end of June 2023, but a full year loss is forecast. Chief executive Jeffrey Auld bought 250,000 shares at 1.95p each. The share price fell a further 7.5% to 1.85p.

Alba Mineral Resources (LON: ALBA) says that the workings at the Clogau gold mine have reflooded and it is waiting for an extension to the higher abstraction rate permit. The share price declined 6.25% to 0.1125p. Investee company GreenRoc Mining (LON: GROC) an operating loss of £415,000 for the six months to May 2023. The focus is larger scale bulk test work at the Amitsoq Lower graphite layer orebody, which will provide more graphite for testing and supplying samples to potential off-takers. The share price rose 2.35% to 4.35p.

Latest News

More Articles Like This